Clinical Trial Update: A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis [Phase 3]

View source ↗

Summary

This clinical trial update reports that a Phase 3 study evaluating regimens containing Quabodepistat for drug-resistant pulmonary tuberculosis is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Quabodepistat (Quabodepistat)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Pulmonary Tuberculosis | Phase 3 | Status: RECRUITING